Management of Severe Sore Throat in Influenza

Symptomatic Management

The European Respiratory Society recommends administering either ibuprofen or paracetamol as first-line analgesics for sore throat pain relief in influenza patients, as both are equally effective for acute pharyngeal symptoms 1
The American Academy of Pediatrics advises against aspirin in children and adolescents with influenza due to the risk of Reye syndrome 3
The British Thoracic Society suggests ensuring adequate hydration and supportive care measures while monitoring for clinical deterioration in patients with severe sore throat in influenza 2

The Centers for Disease Control and Prevention recommend initiating oseltamivir if the patient has acute influenza-like illness with fever, symptomatic for ≤48 hours, and dosing is 75 mg orally twice daily for 5 days 2, 4
The Infectious Diseases Society of America suggests considering antiviral therapy in immunocompromised or very elderly patients who may not mount adequate febrile response, severely ill hospitalized patients, and patients on long-term corticosteroid therapy 2, 4, 5, 6

The American College of Physicians advises against routinely prescribing antibiotics for previously well adults with influenza and sore throat/acute bronchitis in the absence of pneumonia 2, 5, 3
The European Society of Clinical Microbiology and Infectious Diseases recommends considering antibiotics when previously well patients develop worsening symptoms or high-risk patients develop any lower respiratory tract features 2, 5, 7
The Infectious Diseases Society of America suggests immediately initiating antibiotics for any confirmed or suspected influenza-related pneumonia, with antibiotics administered within 4 hours of hospital admission 7, 3, 2

The British Thoracic Society recommends first-line oral co-amoxiclav or tetracycline for non-severe pneumonia, with a duration of 7 days for uncomplicated cases 2, 5, 7
The American Thoracic Society suggests immediate IV combination therapy with broad-spectrum beta-lactamase stable antibiotic plus IV macrolide for severe pneumonia, with a duration of 10 days for severe, microbiologically undefined pneumonia 2, 7, 3

The World Health Organization advises never delaying antiviral treatment while awaiting laboratory confirmation, as clinical diagnosis of influenza is sufficient, and treatment within 24 hours provides maximum benefit 3
The European Respiratory Society recommends not prescribing antibiotics for uncomplicated influenza pharyngitis simply because the sore throat is "severe", as severity of pharyngeal pain alone does not indicate bacterial superinfection 2, 1, 3
The Centers for Disease Control and Prevention suggest remembering that influenza-related pneumonia requires coverage for S. aureus in addition to typical community-acquired pneumonia pathogens, as bacterial co-infection is a major cause of influenza-associated mortality 7, 3